Nathalie Oliveira

Nathalie Oliveira is a seasoned professional in clinical development, safety, and medical affairs, currently serving as Senior Vice President at Fresenius Kabi since June 2022. Previously, Oliveira held the position of Global Medical Lead for Transplantation at Sanofi and Senior Director of Medical Affairs for rare diseases at Sobi - Swedish Orphan Biovitrum AB, where responsibilities included product launches in Europe and strategic territory expansion. Oliveira's extensive experience at Novartis spanned multiple leadership roles, including Franchise Head of Immunology and Dermatology for Asia Pacific, Middle East, and Africa, where significant growth and successful product launches were achieved. Oliveira holds an MD from the University of Geneva and completed a research fellowship at Harvard Medical School.